Coenzyme A (CoASH) is an obligate cofactor for lipids undergoing β-oxidation in peroxisomes. Although the peroxisomal membrane appears to be impermeable to CoASH, peroxisomes contain their own pool of CoASH. It is believed that CoASH enters peroxisomes as acyl-CoAs, but it is not known how this pool is regulated. The mouse nudix hydrolase 7 (NUDT7α) was previously identified in peroxisomes as a CoAdiphosphatase, and therefore suggested to be involved in regulation of peroxisomal CoASH levels. Here we show that mouse NUDT7α mainly acts as an acyl-CoA diphosphatase, with highest activity towards medium chain acyl-CoAs, and much lower activity with CoASH. Nudt7α mRNA is highly expressed in liver, brown adipose tissue and heart, similar to enzymes involved in peroxisomal lipid degradation. Nudt7α mRNA is downregulated by Wy-14,643, a peroxisome proliferator-activated receptor alpha (PPARα) ligand, in a PPARα dependent manner in mouse liver. In highly purified peroxisomes, nudix hydrolase activity is highest with C 6 -CoA and is decreased by fibrate treatment. Under certain conditions, such as treatment with peroxisome proliferators or fasting, an increase in peroxisomal CoASH levels has been reported, which is in line with a decreased expression/activity of NUDT7α. Taken together these data suggest that NUDT7α function is tightly linked to peroxisomal CoASH/acyl-CoA homeostasis.
INTRODUCTION
Coenzyme A (CoASH) is involved in over 100 different reactions in intermediary metabolism and is indispensable in living organisms (for review see (1) ). CoASH is an obligate co-factor in the degradation of lipids in mitochondria and peroxisomes since the β-oxidation of fatty acids requires their activation to the corresponding CoA ester before β-oxidation can proceed. This activation is catalyzed by a large family of acyl-CoA synthetases with multiple localizations in the cell (for review, see (2) ). Intracellular levels of CoASH depend on the metabolic state, and CoASH is compartmentalized in cytosol, mitochondria and peroxisomes, with each organelle suggested to contain its own pool of CoASH. However, the peroxisomal membrane is impermeable to 'bulky' solutes (over 300 Da) including cofactors such as CoASH, NAD(H), NADP(H), together with CoA esters of fatty acids (3) . Several studies suggest that fatty acids are activated on the outside of the peroxisomal membrane, and therefore fatty acids enter peroxisomes in the form of the CoA ester (4), thus bringing CoASH into the peroxisomal lumen. Acyl-CoAs are believed to be transported across the peroxisomal membrane by a family of ATPbinding-cassette transporters (ABC transporters), and to date four ABC transporters have been identified in mammalian peroxisomes, ABCD1-ABCD4 (for review see (4) ).
Peroxisomes are estimated to contain approximately 0.23-0.7 mM CoASH (5, 6) , which can be used for the various oxidation reactions (for review see (7) ). In particular, a pool of CoASH is required for the final step in β-oxidation to proceed, catalyzed by the 3ketoacyl-CoA thiolases or the sterol carrier protein x, where a molecule of free CoASH is required to form a chain-shortened acyl-CoA, with the concomitant release of acetyl-CoA or propionyl-CoA (depending on the substrate oxidized).
CoASH levels in peroxisomes can portentially be regulated by members of three enzyme families, the acyl-CoA thioesterases (ACOTs), the nudix hydrolases (NUDTs), and the carnitine acyltransferases. The ACOTs catalyze the hydrolysis of acyl-CoAs to the free fatty acid and CoASH (for review see (8) ), while the nudix (nucleoside diphosphate linked to another moiety X) hydrolases are active on CoASH and cleave CoASH to 4'-phosphopantetheine and 3',5'-ADP (9,10) (see Fig. 1 for the site of hydrolysis by ACOTs and NUDT enzymes in an acyl-CoA molecule). Six ACOT enzymes have been identified in mouse peroxisomes: ACOT3-6, active on long chain acyl-CoAs, succinyl-CoA, medium chain acyl-CoAs, and branched chain acyl-CoAs respectively (11) (12) (13) (14) ; ACOT8, active on a broad range of acyl-CoAs (15, 16) ; and ACOT12, active on short chain acyl-CoAs (mainly acetyl-CoA) (17) . Two nudix hydrolases active on CoASH or CoA derivatives have been identified in mammalian peroxisomes, the NUDT7 (18) and NUDT19 (RP2p) (19) . These enzymes function as diphosphatases that can cleave CoASH or CoA esterified to a fatty acid, with the resulting products being 4'-phosphopantetheine or acyl-phosphopantetheine (a fatty acid backbone with a 4'-phosphopantetheine) and 3',5'-ADP. The mouse NUDT7α was first characterized in 2001 and expression of recombinant protein showed that this enzyme hydrolyzed CoASH, 3'-dephospho-CoA, oxidized CoA (CoASSCoA), acetyl-CoA and succinyl-CoA, with the K m for these substrates ranging from 230 µM to 480 µM (18) .
Two isoforms of mouse Nudt7 have been identified, the Nudt7α and Nudt7β (18) . The NUDT7α is a peroxisomal coenzyme A diphosphatase, while the Nudt7β is an inactive splice variant. The Nudt19 was identified by proteomic analysis of mouse kidney peroxisomes as a CoA diphosphatase with activity towards CoASH, oxidized CoA and a wide range of CoA esters, including bile acid-CoAs and branched chain acyl-CoAs (19) .
Peroxisomes also contain two carnitine acyltransferases (carnitine acetyltransferase and carnitine octanoyltransferase) that transfer fatty acids from CoASH to carnitine for subsequent transport to mitochondria.
There are some literature reports suggesting that the peroxisomal CoASH pool is increased in liver in response to peroxisome proliferator treatment and by fasting (5) .
This may be due to several factors, (a) an increase in uptake of acyl-CoAs into peroxisomes under these conditions (i.e increased peroxisomal β-oxidation activity), (b) changed activities of ACOTs and carnitine acyltransferases, and (c) regulation of nudix hydrolase activity that would regulate CoASH levels in peroxisomes. Since the activity of mouse NUDT7α was originally only characterized with CoASH and a very limited set of short-chain acyl-CoA's (18) , we therefore set out to perform a more in-depth study on the activity of NUDT7α. We have examined the substrate specificity of NUDT7α and show that this enzyme mainly hydrolyzes medium chain acyl-CoAs and bile acid-CoAs. We show that Nudt7α mRNA is mainly expressed in liver, brown adipose tissue and heart, tissues that also have high expression of the peroxisomal β-oxidation enzymes acyl-CoA oxidase 1 and multifunctional protein 2 (20) . The Nudt7α mRNA is downregulated in liver during conditions that alter the metabolic status of peroxisomes, such as treatment with the peroxisome proliferator-activated receptor alpha (PPARα) ligand Wy-14,643. In line with this, nudix hydrolase activity was also downregulated in highly purified mouse liver peoxisomes following clofibrate treatment. Interestingly the highest nudix hydrolase activity in peroxisomes is with C6-CoA which is about 12 times higher than the activity with CoASH. Our results show that NUDT7α is likely an important auxiliary enzyme in regulating peroxisomal acyl-CoA/CoASH levels, the latter being imperative for βoxidation to proceed.
Materials and methods

Cloning and expression of mouse Nudt7α-
The open reading frame of mouse Nudt7α was amplified from mouse kidney total RNA using the following primers 5'-CATATGTCGCGACCTTGTGGAC-3' and 5'-CATATGGGGTCTTCACAACTTGCTTAAAG-3', with NdeI sites indicated in bold.
Reverse Transcriptase PCR was performed using the Takara One
Step RNA PCR kit using the following program: 50ºC for 30 min, 94ºC for 2 min, followed by 30 cycles of 94ºC for 30 sec, 55ºC for 30 sec and 72ºC for 2 min. The Nudt7α PCR product was cloned into the NdeI site in pET-16b vector (Novagen Corp) and fully sequenced.
Alternatively, the Nudt7α was cloned into the pMal-C2X vector (New England Biolabs) to express NUDT7α as a fusion protein with the maltose binding protein (MBP). The Nudt7α plasmid was then used to transform BL21(DES3)pLysS cells (Novagen Inc). For expression of NUDT7α, bacteria were cultured in Luria-Bertani medium at 37ºC, in the presence of 50 µg/ml ampicillin and 34 µg/ml chloramphenicol until an A 600 of approximately 0.6 was reached. Protein expression was induced by the addition of 1 mM isopropyl-1-thio-β-D-galactopyranoside and growth was continued for 3 hours. The bacteria were collected and frozen at -20°C.
Bacterial pellets were thawed and resuspended in Bug Buster TM protein extraction reagent (Novagen Inc) with the addition of Benzonase (Novagen Inc.), incubated at room temperature for 20 minutes and centrifuged at 4,200 x g for 20 min at 4 o C. The supernatants were then used for purification of his-tagged NUDT7α on a His-Trap TM column (Amersham Biosciences) or purification of the MBP-fusion protein on amylose resin as described by the manufacturer (New England Biolabs). These purified fractions were subsequently used for activity measurements. Protein concentration was determined using the Bradford assay (21) .
Determination of recombinant nudix hydrolase activity-
NUDT7α activity was measured using two different assays. For the HPLC-based assay, were terminated by addition of 25 µl of 2 M perchloric acid and neutralized with potassium carbonate. Samples were centrifuged at 12,000 x g for 10 min at 4°C. Samples were diluted with an equal volume of 100 mM ammonium phosphate (buffer A). and metabolites were analyzed on a HPLC system using a 250 mm x 4.6 mm Supelcosil LC-18-S column equilibrated with buffer A at a flow rate of 1 ml/min as described in (19) .
The metabolites were eluted from the column with a linear gradient of 20 min changing from 100% buffer A to 100% buffer B (buffer A/acetonitrile 50:50). Absorption was measured at 260 nm using Chromeleon software. The specific activity was calculated based on measurement of 3',5'-ADP produced, using two separate NUDT7α protein preparations.
For the determination of K m and V max with different substrates, NUDT7α activity was measured using an assay that is based on quantitation of released phosphate by co-incubation with alkaline phosphatase in principal as described earlier (22, 23) . were terminated by addition of 700 µl of a mixture containing ascorbic acid and ammonium molybdate in H 2 SO 4 and incubated at 37 o C for more than one hour, and the absorbance was measured at 820 nm. The amount of free phosphate was calculated using A 820 =0.260 is equivalent to 10 nmol of inorganic phosphate (Pi) (23) . Control reactions without NUDT7α protein were carried out for each individual substrate at each concentration to determine the NUDT7α independent release of Pi by the alkaline phosphatase due to its activity towards the 3'-phosphate in CoASH (see *** in Fig.1 ).
This background activity was subtracted from the test reaction containing NUDT7α to establish the amount of NUDT7α-dependent Pi generated from the production of acylphosphopanthetheine (one phosphate per molecule) and 3',5'-ADP (one phosphate per molecule). The activity measurements were performed using three separate preparations of recombinant NUDT7α and enzyme kinetics were calculated using Prism Enzyme Kinetics software.
Determination of nudix hydrolase activity in purified peroxisomes-
Nudix hydrolase activity was determined in mouse liver peroxisomes from control animals or animals treated with 0.5% clofibrate for one week, isolated as described in (13) . Activity was determined by incubating 50 µg purified liver peroxisomes with 150 µM C 14 -CoA thioether (Avanti Polar Lipids), or 250 µM C 6 -CoA or 250 µM CoASH in 100mM Tris/HCl pH8, with or without the addition of 5mM MgCl 2 . Reactions were terminated by adding 50 µl of 0,5M perchloric acid to each incubation, followed by neutralization with 2 M KOH/10 mM MES buffer until a pH of 6-7 was reached. Samples were then centrifuged at 14,000 rpm for 10 min at 4°C and the supernatant was removed. 20 µl of the supernatant was analyzed on a HPLC system using a 250mm x 4.6 Beckman
Ultrasphere C-18 analytical column, as described above.
Animals and treatments-
Tissues were excised from adult male wild-type (+/+) mice or PPARα null (-/-) mice on a pure Sv/129 background (24) . The mice were fed either a standard chow diet or diets containing 0.1% Wy-14,643 (Calbiochem-Novabiochem International) or 0.5% (w/w) clofibrate (ICI Pharmaceuticals, Macclesfield, Cheshire, UK) for 1 week before sacrifice.
Animals were sacrificed by CO 2 asphyxiation followed by cervical dislocation. Tissues were excised and stored at -70 o C for preparation of total RNA. All animal experiments were carried out with ethical permission obtained from the Animal Experimental Ethical Committee, Stockholm.
RNA isolation and cDNA synthesis-
Total RNA was isolated from various mouse tissues using Trizol reagent (Invitrogen Corporation, CA, USA). Total RNA was treated with DNase I (Promega Corporation, Madison, WI, USA) prior to cDNA synthesis and the quality of RNA was analyzed on a 1% agarose/formaldehyde gel. For the tissue expression studies RNA from three individual animals was pooled. For the regulation studies by Wy-14,643, three individual animals in each group were used. cDNA synthesis was performed using 1 µg of total RNA using Taqman Reverse Transcription reagents (Applied Biosystems Inc). The following primers were used: Nudt7α -Fwd 5'-CCGAAGTCTCCTGCTGCTAGTA -3', 
RESULTS
The Nudt7 gene is alternatively spliced to encode three possible open reading frames
We performed searches in the Expressed Sequence Tag (EST) database, which indeed revealed the existence of both Nudt7α and Nudt7β (although Νudt7α is  the dominating  isoform with 43 of 51 ESTs corresponding to Nudt7α). However, these searches also identified a further splice variant (designated Nudt7γ), which would result in an in-frame open reading frame that is 24 amino acids longer than Nudt7α. Translation of NUDT7α begins at an ATG, which results in a protein of 236 amino acids, however, NUDT7γ is translated from an alternative ATG start site, which is spliced out in NUDT7α, resulting in a protein of 260 amino acids ( Fig. 2a and 2b) . Again, database searches of EST clones revealed that out of 55 ESTs, only 4 corresponded to the Nudt7γ.
The Nudt7 isoforms are mainly expressed in liver, brown adipose tissue and heart
The tissue expression of both Nudt7α and Nudt7γ was examined using real-time PCR.
Nudt7α showed highest expression in liver, followed by brown adipose tissue, heart and white adipose tissue (Fig. 3a ). An amplicon at the 5'-end of Nudt7γ could be amplified and real-time PCR was used to examine the expression levels of the two variants relative to each other in the tissues in which Nudt7α is most highly expressed. The levels of
Nudt7γ are approximately 20 times lower than Nudt7α, although the pattern of tissue expression was similar (Fig. 3b ). Due to the very weak expression of Nudt7γ , this protein was not further characterized in this study.
Peroxisomal nudix hydrolase Nudt7α is regulated via the PPARα
As stated previously, it has been reported that the peroxisomal CoASH pool is increased in liver in response to treatment by peroxisome proliferators. As a downregulation of nudix hydrolase activity should result in an increase in CoASH pools, we therefore examined the nudix hydrolase activity in purified peroxisomes, together with mRNA expression of Nudt7α, in response to peroxisome proliferators. Interestingly, treatment with the PPARα activator Wy-14,643 resulted in a decrease in Nudt7α mRNA in mouse liver (Fig. 4a ). This downregulation at mRNA level was not evident in the PPARα knockout mouse model, showing that it is a PPARα dependent effect. Keeping in mind that the cytoplasmic area of the peroxisome is increased by peroxisome proliferators (5-8 fold) (25, 26) , it is likely that NUDT7α activity is strongly decreased in relation to peroxisomal β-oxidation, which would preserve CoASH and may explain the increased CoASH levels seen in peroxisomes in response to peroxisome proliferator treatment.
To confirm that the decreased expression of Nudt7α mRNA is reflected in decreased nudix hydrolase activity, the activity was measured in highly purified peroxisomes isolated from control and clofibrate treated mouse liver, using CoASH, C 6 -
CoA and a C 14 -CoA thioether (the use of the C 14 -CoA thioether circumvents any possible interference by ACOTs when measuring nudix hydrolase activity). Interestingly, nudix hydrolase activity in peroxisomes was highest with C 6 -CoA (a medium chain acyl-CoA), followed by C 14 -CoA, and much lower with CoASH (Fig. 4b) . The activity towards C 6 -CoA and C 14 -CoA were reduced 70% and almost 40% respectively, following clofibrate treatment. Nudix hydrolase activity towards CoASH was however not changed in peroxisomes following clofibrate treatment.
NUDT7α is a medium chain acyl-CoA diphosphatase
The co-expression of Nudt7α with straight-chain β-oxidation enzymes in liver and brown adipose tissue, together with the regulation by PPARα points to a role for this enzyme as an auxiliary enzyme in β-oxidation, likely in regulating CoASH homeostasis. The observation that nudix hydrolase activity in isolated peroxisomes is considerably higher with acyl-CoAs than with CoASH suggests that acyl-CoAs may be the preferred substrates for NUDT7α. We therefore expressed recombinant mouse NUDT7α and reinvestigated the activity towards longer chain acyl-CoAs. The recombinant protein was very easily produced in good amounts of high purity (data not shown). Activity measurements with CoASH and various acyl-CoAs at a fixed concentration of 200 µM (using the HPLC method) showed a very broad specificity, with lower enzyme activity with longer chain acyl-CoAs, and the best substrates being medium chain acyl-CoAs, choloyl-CoA and trihydroxycoprostanoyl-CoA (THCA-CoA) (Fig. 5a ).
In order to determine the kinetic parameters (V max and K m ) of NUDT7α we used a method based on quantitation of inorganic phosphate released by co-incubation with alkaline phosphatase. Parallel incubations were carried out for each substrate and substrate concentration ± NUDT7α protein in order to determine the amount of inorganic phosphate released by alkaline phosphatase due to the NUDT7α reaction. The K m values are in the range of 22 to 242 µM, and V max values between 0.13 to 1.8 µmol/min/mg. The kinetics curves for CoASH, C 6 -CoA and C 12 -CoA are shown in Fig. 5b, demonstrating proper Michelis Menten kinetics, and that the method is appropriate for these measurements. Table 1 summarizes the kinetic characterization with a number of substrates, which shows that the K m values are highest with CoASH and short-chain acyl-CoAs, with substantially lower K m for medium to long chain acyl-CoAs, with the exception of C10-CoA. The reason for the higher K m with C10-CoA is not clear, but was consistent between enzyme preparations and using two different commercial batches of C 10 -CoA. In contrast, V max values are much higher with medium-chain acyl-CoAs (C 6 -C 12 -CoA), suggesting that these acyl-CoAs are the best substrates for NUDT7α. It should be noted that the activity with CoASH reported here is much lower than the activity reported previously (18) , however the reason for this difference is not clear. The consistently higher activities with increasing acyl chain length suggests that acyl-CoAs are the preferred substrates and the kcat and kcat/Km values obtained with medium chain acyl-CoAs support this notion. Thus, NUDT7α is a CoA diphosphatase, but the enzyme preferentially hydrolyzes medium chain acyl-CoAs and bile acid-CoAs, suggesting a role mainly in acyl-CoA metabolism.
DISCUSSION
Peroxisomes contain their own pool of CoASH, but at present intraperoxisomal CoASH homeostasis is poorly understood. The current view is that the peroxisomal membrane is impermeable to CoASH, and no CoASH-transporter has been identified to date.
Therefore it appears that CoASH enters peroxisomes via ABC-transporters in the form of acyl-CoAs, and with no known mechanism of transport of CoASH out of the peroxisomes, the fate of intraperoxisomal CoASH remains unknown. There are however a number of enzymatic systems within the peroxisome that could be involved.
Peroxisomes have long been known to contain short-and medium-chain carnitine acyltransferases that convert the CoA-ester of fatty acids to the corresponding carnitine ester for transport to mitochondria, leaving CoASH in the peroxisomal lumen. Similarly, recently identified ACOTs are likely involved in release of non-esterified fatty acids for exit out of the peroxisome, also leaving CoASH in the peroxisomal lumen (for review, see (8)). However, the recent identification of two CoASH metabolizing enzymes, NUDT7 and NUDT19, provided a very promising, and seemingly simple, explanation for metabolism of CoASH in peroxisomes. Nevertheless, this is complicated by the finding that in fact both NUDT19 (19) and NUDT7α (this study) are much more active on acyl-CoAs rather than CoASH. Although nudix hydrolase activity in purified peroxisomes was tested on a limited number of substrates in this study, the activity pattern reveals much higher activity with medium chain acyl-CoAs (C 6 -CoA) and longer chain (C 14 -CoA) acyl-CoAs than with CoASH. This is supported by the kinetics of the recombinant Nudt7α protein, with highest kcat/K m values with medium to long chain acyl-CoAs. This combined data supports that NUDT7α is mainly an acyl-CoA diphosphatase. Therefore, a possible function for the NUDT enzymes could be to metabolize CoA esterified to fatty acids, and thereby terminate β-oxidation. As NUD7α is mainly active on medium-chain acyl-CoAs, this would allow longer-chain acyl-CoAs to undergo more cycles of βoxidation than medium-chain acyl-CoAs and may provide an explanation as to the previously reported "function" of peroxisomal β-oxidation to act as a chain-shortening system.
The PPARα is a key nuclear receptor involved in the regulation of lipid metabolism and many genes in peroxisomal β-oxidation are targets of this nuclear receptor (27) .
Conditions such as fasting and fibrate treament, which activate the PPARα (24, 28, 29) , result in an increase of peroxisomal total and free CoASH levels (5) . While little is known about the regulation of nudix hydrolases under these or other conditions, microarray expression analysis shows that Nudt7α is downregulated by fasting for 24 and 48 hr in mice (30) and is also strongly upreglated by thyroid hormone (31) . We now show that the Nudt7α is downregulated by Wy-14,643 treatment, in a PPARα-dependent manner in mouse liver. Analysis of the promotor region of Nudt7α reveals a direct repeat 1 (DR1 -TGACCTGTGACCT) at -959 to -971 upstream of the ATG start site, which could potentially bind the PPARα/RXR heterodimer. As this is a 'perfect ' DR1 sequence, it is likely to be promiscuous in binding PPARα/RXR heterodimers and other candidate nuclear receptors such as HNF-4α, COUP/TF/RXR, and RAR/RXR. Further work is however required to characterize this promotor element which is likely involved in the PPARα agonist effects seen in this study. In conclusion therefore, during conditions of high requirement for CoASH in peroxisomes (when β-oxidation activity is high), Nudt7α is downregulated to preserve CoASH in peroxisomes, which can be used in the thiolase reaction of β-oxidation.
Apart from NUDT7α and NUDT19, a further nudix hydrolase has been identified in mammalian peroxisomes, named NUDT12, which is an NADH diphosphatase (32) . As the peroxisomal membrane is impermeable to cofactors such as CoASH synthesis outside the peroxisome (for review see (1)). In mammalian cells, the first three steps of the CoA synthesis pathway are catalyzed by proteins located in the cytosol (33, 34) , while the last two reactions take place on the outer mitochondrial membrane (35) . It is therefore possible that the 4'-phosphopantetheine could be exported from peroxisomes and reused in CoASH synthesis. The fate of the 3',5'-ADP produced in peroxisomes is also unknown. In yeast and human peroxisomes, two adenine nucleotide transporters, Ant1 and PMP34, have been identified that transport adenine nucleotides across the peroxisomal membrane (36, 37) and therefore 3',5'-ADP may be transported out of the peroxisome lumen. Interestingly, ADP is also a potent inhibitor of ACOT12 (38), a peroxisomal short chain acyl-CoA thioesterase that can hydrolyze mainly acetyl-CoA (17, 39, 40) , which suggests a role for nucleotides such as ADP in the regulation of acetate formation in peroxisomes.
ACOT enzymes in peroxisomes may act as a complementary system with NUDT7α and NUDT19 in regulation of acyl-CoA/CoASH levels (see Fig. 1 ). NUDT activity with acyl-CoAs will result in formation of acyl-phosphopanthetheine and 3',5'-ADP, which will be produced in parallel with ACOT enzyme products (CoASH and free fatty acids) in some tissues. This raises the question as to the fate of acylphosphopanthetheine in peroxisomes. Interestingly, preliminary data suggests that ACOT3 and ACOT8 can in fact hydrolyze the acyl-phosphopanthetheine (the product of the NUDT7α reaction), resulting in a free fatty acid and 4'-phosphopanthetheine. This may solve some of the mystery as to why both enzyme families would use the same substrate in peroxisomes. However, further work is underway to establish the role of the ACOTs and NUDTs in regulation of peroxisomal acyl-CoA/CoA levels. 
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